Dabigo 110mg Capsule
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Dabigatran Etexilate (110mg)
Overview Dabigo 110mg Capsule
A blood thinner, Dabigo 110mg Capsule, prevents and manages blood clots. This medication lowers stroke and heart attack risk by inhibiting clot formation in leg, lung, brain, and heart veins. Frequently prescribed for patients with atrial fibrillation to prevent clots, it also mitigates clotting risks following knee or hip replacement. Dabigo 110mg may be taken with or without food, but consistent daily timing is recommended. Long-term use, potentially lifelong, may be necessary; discontinuation or dosage alteration requires physician approval to avoid increased risk of stroke, heart attack, or thrombosis. Lifestyle modifications—such as diet, exercise, weight management, and smoking cessation—further reduce clot risk. Common side effects include gastrointestinal upset and increased bleeding susceptibility (e.g., nosebleeds, bruising). Report any adverse effects promptly to your doctor. Other potential side effects encompass headaches, seizures, allergic reactions, visual disturbances, and fatigue. Contraindicated in individuals with severe liver or kidney disease, active bleeding, or concurrent use of other anticoagulants, breastfeeding is also inadvisable while using this medication. Unlike some anticoagulants, routine PT-INR monitoring isn't needed.
Primary Ingredients of Dabigo 110mg Capsule
No text was provided to rewrite.
Uses of Dabigo 110mg Capsule
Preventing and managing blood clot formation.
Major Benefits of Dabigo 110mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dabigo 110mg Capsules can be administered with or without food, although consistent timing is recommended.
Common Side effects of Dabigo 110mg Capsule:
- Nausea
- Anemia (low number of red blood cells)
- Gastrointestinal bleeding
- Dyspepsia
- Diarrhea
- Abdominal pain
- Nosebleeds
- Skin bleeding
How to use Dabigo 110mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dabigo 110mg Capsules can be ingested with or without food; however, consistent daily timing is recommended.
How Dabigo 110mg Capsule works:
Lixiana 110mg capsules represent a new class of oral blood thinners. Their mechanism of action involves inhibiting blood clot development.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Dabigo 110mg Capsules is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dabigo 110mg capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Dabigo 110mg capsules while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Dabigo 110mg capsules.
KidneyCAUTION
Individuals with severely impaired kidney function should exercise caution when using Dabigo 110mg capsules. Dosage modification may be necessary. Physician consultation is advised. Dabigo 110mg capsules are generally unsuitable for patients with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Dabigo 110mg capsules cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Dabigo 110mg Capsule :
Should you forget a Dabigo 110mg Capsule dose, take it immediately if still within the same day. However, omit the missed dose if you cannot administer it at least six hours prior to your next scheduled dose. Never compensate for a missed dose by taking a double dose.
Facts to Know About Dabigo 110mg Capsule
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole-based compound |
| Developing Habits | No. |
| Type of Treatment | Heart |
| Action Class | Oral direct thrombin inhibitor |






